Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2413 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

30 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2019-10-03 2019-10-10 95370
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
PORTIA 28 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94874
PORTIA 21 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94870
TEVA-LEVOCARBIDOPA 25MG 100MG TABLET Resolved 2019-09-26 2019-10-10 94864
TEVA-LACOSAMIDE 150MG TABLET Resolved 2019-10-03 2019-10-10 95387
PEMETREXED DISODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-10-17 93140
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
ACT RIZATRIPTAN 10MG TABLET Resolved 2019-09-05 2019-10-17 93169
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-22 2019-10-24 92229
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92666
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92669
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92678
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92681
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2019-10-17 2019-10-26 96730
AVIANE 28 20MCG 100MCG TABLET Resolved 2019-09-26 2019-11-01 94828

Showing 401 to 420 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63949
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63983
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63986
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63989
ACT OXYCODONE CR 80MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63992
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64538
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64541

Showing 21 to 40 of 250